| Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study |
18 |
| Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation |
15 |
| The use of digital pathology and image analysis in clinical trials |
14 |
| Current status of clinical testing for human papillomavirus in oropharyngeal squamous cell carcinoma |
13 |
| Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma |
13 |
| Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability |
12 |
| Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patients |
12 |
| Biomarker discovery for renal cancer stem cells |
10 |
| Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-angiogenic therapies |
10 |
| Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastases |
9 |
| The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis |
9 |
| Cancer immunophenotyping by seven-colour multispectral imaging without tyramide signal amplification |
8 |
| Breast cancer metastasis to gynaecological organs: a clinico-pathological and molecular profiling study |
8 |
| FOXC2 expression and epithelial-mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer |
7 |
| Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervix |
6 |
| Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers |
5 |
| Histological scoring of immune and stromal features in breast and axillary lymph nodes is prognostic for distant metastasis in lymph node-positive breast cancers |
5 |
| Combined epithelial marker analysis of tumour budding in stage II colorectal cancer |
5 |
| Rapid amplification of prions from variant Creutzfeldt-Jakob disease cerebrospinal fluid |
5 |
| Breast cancer in patients with germline TP53 pathogenic variants have typical tumour characteristics: the Cohort study of TP53 carrier early onset breast cancer (COPE study) |
4 |
| A gene signature associated with PTEN activation defines good prognosis intermediate risk prostate cancer cases |
4 |
| Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms |
4 |
| High immune cytolytic activity in tumor-free tongue tissue confers better prognosis in patients with squamous cell carcinoma of the oral tongue |
4 |
| Quality assurance guidance for scoring and reporting for pathologists and laboratories undertaking clinical trial work |
4 |
| Comprehensive three-dimensional morphology of neoangiogenesis in pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis |
4 |
| Training and accreditation standards for pathologists undertaking clinical trial work |
3 |
| Novel prognostic markers within the CD44-stromal ligand network in pancreatic cancer |
3 |
| Atypical tuberous sclerosis complex presenting as familial renal cell carcinoma with leiomyomatous stroma |
3 |
| Reduced lymphotoxin-beta production by tumour cells is associated with loss of follicular dendritic cell phenotype and diffuse growth in follicular lymphoma |
3 |
| Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy |
3 |
| High frequency of CD74 expression in lymphomas: implications for targeted therapy using a novel anti-CD74-drug conjugate |
3 |
| Intranuclear inclusions in hepatocellular carcinoma contain autophagy-associated proteins and correlate with prolonged survival |
3 |
| A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma |
2 |
| Plasma proteome plus site-specific N-glycoprofiling for hepatobiliary carcinomas |
2 |
| Genomic profiling identifies GPC5 amplification in association with sarcomatous transformation in a subset of uterine carcinosarcomas |
2 |
| ColX alpha 1 is a stromal component that colocalizes with elastin in the breast tumor extracellular matrix |
2 |
| A novel ANO5 splicing variant in a LGMD2L patient leads to production of a truncated aggregation-prone Ano5 peptide |
2 |
| Morphological and molecular motifs of fibrosing pulmonary injury patterns |
2 |
| Characterisation of the endocrine pancreas in type 1 diabetes: islet size is maintained but islet number is markedly reduced |
2 |
| Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression |
2 |
| Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer |
2 |
| The new screening program to prevent cervical cancer using HPV DNA: getting the balance right in maintaining quality |
1 |
| Anaplastic lymphoma kinase (ALK) gene rearrangements in radiation-related human papillary thyroid carcinoma after the Chernobyl accident |
1 |
| Optimization of commercially available Zika virus antibodies for use in a laboratory-developed immunohistochemical assay |
1 |
| IDK1 is a rat monoclonal antibody against hypoglycosylated bone sialoprotein with application as biomarker and therapeutic agent in breast cancer skeletal metastasis |
1 |
| Tumour cell expression of interleukin 6 receptor alpha is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma |
1 |
| Disparate cell proliferation and p53 overexpression in colonic crypts with normal epithelial lining found below the neoplastic canopy of conventional adenomas |
1 |
